Despite progress in cancer biology, deciphering the spatial architecture of the tumor microenvironment remains a challenge.

As we mark Breast Cancer Awareness Month this October, we celebrate the work of Kornelia Polyak, a pioneering cancer ...

Breast cancer (BRCA) remains the most common malignant cancer in women worldwide. Although a range of treatments exists, ...

Abnormal cell proliferation is a major hallmark of cancer. Several proteins are involved in the cell cycle, and most of these ...

NUC-7738 Synergizes with PD-1 Inhibitors to Promote Cancer Cell Death Data Reinforces Mechanism of Action along with Efficacy and Safety Profile ...

Study reveals how TP53 mutations alter lung adenocarcinoma tumour microenvironment, influencing progression and immunotherapy ...

Cancer cells don’t exist in isolation – instead, they live within a complex ecosystem that also includes immune cells, stromal cells, the extracellular matrix, blood vessels and many other factors.

The tumor microenvironment (TME) constitutes the tumor, extracellular matrix (ECM) and several non-transformed cells, such as immune infiltrates, fibroblasts and vascular vessels recruited from ...

GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-TKI, a novel multi-receptor tyrosine kinase inhibitor for cancer immunotherapy. GNTbm-TKI will be presented as posters at the ...